Gara Jalqabaatti › Dermatitis Atopic (Eczema) › Oregon
Qorannoo klinikaalii Dermatitis Atopic (Eczema) Oregon keessatti
Qorannoo 6 Dermatitis Atopic (Eczema) f Oregon keessatti hirmaatuu jiru.
Magaalota Oregon keessatti
Takkalaa qorannoo (Ingiliffa)
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Portland
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 3, Portland
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Oregon Health and Science University /ID# 266483, Portland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 11 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Portland
Namoota walitti qabaa jiraSadarkaa 3
6 Months – 11 Years · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Oregon Health and Science University /ID# 263736, Portland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 63 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06389136Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7073, Gresham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06988605Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.